Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
May 10, 2026
Randomized non-comparative phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma unable for cisplatin-based chemotherapy. NIVOTAX TTCC study
Lara Iglesias Docampo, Neus Basté, Marc Oliva, et al.
Oral Oncology
|
February 21, 2026
An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion)
Panagiota Economopoulou, Abraham Pouliakis, Miltiades Kyprianou, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2021
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
Marc Oliva, Douglas Chepeha, Daniel V Araujo, et al.
Nature Communications
|
August 27, 2021
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
S Y Cindy Yang, Scott C Lien, Ben X Wang, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
Integration of Patient-Reported Outcome Measures in Clinical Practice for Head and Neck Cancer Patients: A Cross-Sectional Survey
Tatiana Dragan, Niclas Hubel, Jens Lehmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 10, 2026
Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project
Paula Sàbat, Maria Ajenjo-Bauza, Cinta Hierro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2026
Amivantamab in recurrent/metastatic HNSCC after checkpoint inhibitor and chemotherapy: pivotal results from the phase 1b/2 OrigAMI-4 study
Barbara Burtness, Ari J Rosenberg, Benoit Calderon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 4, 2026
Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial
Hye Ryun Kim, Marc Oliva, Sebastien Salas, et al.
The New England Journal of Medicine
|
June 18, 2025
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
Ravindra Uppaluri, Robert I Haddad, Yungan Tao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2025
Accuracy and Prognosis of Extranodal Extension on Radiologic Imaging in Human Papillomavirus-Mediated Oropharyngeal Cancer: a Head and Neck Cancer International Group (HNCIG) real-world study
Hisham Mehanna, Ahmad K Abou-Foul, Christina Henson, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
European Journal of Cancer (Oxford, England : 1990)
|
May 10, 2026
Randomized non-comparative phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma unable for cisplatin-based chemotherapy. NIVOTAX TTCC study
Lara Iglesias Docampo, Neus Basté, Marc Oliva, et al.
Oral Oncology
|
February 21, 2026
An observational retro-prospective study on patients with head and neck cancer who contracted COVID-19 (HERODOTUS: head and neck cancERs international cOviD-19 collabOraTion)
Panagiota Economopoulou, Abraham Pouliakis, Miltiades Kyprianou, et al.
Journal for Immunotherapy of Cancer
|
October 2, 2021
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
Marc Oliva, Douglas Chepeha, Daniel V Araujo, et al.
Nature Communications
|
August 27, 2021
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
S Y Cindy Yang, Scott C Lien, Ben X Wang, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
Integration of Patient-Reported Outcome Measures in Clinical Practice for Head and Neck Cancer Patients: A Cross-Sectional Survey
Tatiana Dragan, Niclas Hubel, Jens Lehmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 10, 2026
Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project
Paula Sàbat, Maria Ajenjo-Bauza, Cinta Hierro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2026
Amivantamab in recurrent/metastatic HNSCC after checkpoint inhibitor and chemotherapy: pivotal results from the phase 1b/2 OrigAMI-4 study
Barbara Burtness, Ari J Rosenberg, Benoit Calderon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 4, 2026
Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial
Hye Ryun Kim, Marc Oliva, Sebastien Salas, et al.
The New England Journal of Medicine
|
June 18, 2025
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
Ravindra Uppaluri, Robert I Haddad, Yungan Tao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2025
Accuracy and Prognosis of Extranodal Extension on Radiologic Imaging in Human Papillomavirus-Mediated Oropharyngeal Cancer: a Head and Neck Cancer International Group (HNCIG) real-world study
Hisham Mehanna, Ahmad K Abou-Foul, Christina Henson, et al.
Page
of 7